Literature DB >> 17681181

Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats.

Anna C Piscaglia1, Thomas D Shupe, Seh-Hoon Oh, Antonio Gasbarrini, Bryon E Petersen.   

Abstract

BACKGROUND AND AIMS: Hepatic regeneration is a heterogeneous phenomenon involving several cell populations. Oval cells are considered liver stem cells, a portion of which derive from bone marrow (BM). Recent studies have shown that granulocyte-colony stimulating factor (G-CSF) may be effective in facilitating liver repair. However, it remains unclear if G-CSF acts by mobilizing BM cells, or if it acts locally within the liver microenvironment to facilitate the endogenous restoration program. In the present study, we assessed the involvement of G-CSF during oval cell activation.
METHODS: Dipeptidyl-peptidase-IV-deficient female rats received BM transplants from wild-type male donors. Four weeks later, rats were subjected to the 2-acetylaminofluorene/partial hepatectomy model of oval cell-mediated liver regeneration, followed by administration of either nonpegylated G-CSF or pegylated G-CSF. Control animals did not receive further treatments after surgery. The magnitude of oval cell reaction, the entity of BM contribution to liver repopulation, as well as the G-CSF/G-CSF-receptor expression levels were evaluated. In addition, in vitro proliferation and migration assays were performed on freshly isolated oval cells.
RESULTS: Oval cells were found to express G-CSF receptor and G-CSF was produced within the regenerating liver. G-CSF administration significantly increased both the magnitude of the oval cell reaction, and the contribution of BM to liver repair. Finally, G-CSF acted as a chemoattractant and a mitogen for oval cells in vitro.
CONCLUSIONS: We have shown that G-CSF facilitates hepatic regeneration by increasing the migration of BM-derived progenitors to the liver, as well as enhancing the endogenous oval cell reaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681181      PMCID: PMC3130597          DOI: 10.1053/j.gastro.2007.05.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

Review 1.  Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor.

Authors:  John Thomas; Fulu Liu; Daniel C Link
Journal:  Curr Opin Hematol       Date:  2002-05       Impact factor: 3.284

2.  Stem cells and liver disease: promise laced with confusion and intrigue.

Authors:  Nick A Shackel; Don C Rockey
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

3.  Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor.

Authors:  Rie Imamura; Toshihiro Miyamoto; Goichi Yoshimoto; Kenjiro Kamezaki; Fumihiko Ishikawa; Hideho Henzan; Koji Kato; Ken Takase; Akihiko Numata; Koji Nagafuji; Takashi Okamura; Michio Sata; Mine Harada; Shoichi Inaba
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

Review 4.  Microarray RNA/DNA in different stem cell lines.

Authors:  A C Piscaglia; T Shupe; A Gasbarrini; B E Petersen
Journal:  Curr Pharm Biotechnol       Date:  2007-06       Impact factor: 2.837

5.  Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat.

Authors:  B E Petersen; J P Goff; J S Greenberger; G K Michalopoulos
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

6.  Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

Authors:  W-R Schäbitz; R Kollmar; M Schwaninger; E Juettler; J Bardutzky; M N Schölzke; C Sommer; S Schwab
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

7.  How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model.

Authors:  A C Piscaglia; M A Zocco; C Di Campli; L Sparano; S Rutella; G Monego; G Bonanno; F Michetti; S Mancuso; P Pola; G Leone; G Gasbarrini; A Gasbarrini
Journal:  Dig Liver Dis       Date:  2005-10-07       Impact factor: 4.088

8.  G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Authors:  Evangelia Yannaki; Evangelia Athanasiou; Angeliki Xagorari; Varnavas Constantinou; Ioannis Batsis; Panagiotis Kaloyannidis; Evangelia Proya; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Exp Hematol       Date:  2005-01       Impact factor: 3.084

9.  Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers.

Authors:  Bryon E Petersen; Brian Grossbard; Heather Hatch; Liya Pi; Jie Deng; Edward W Scott
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

10.  Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy.

Authors:  Stamatios E Theocharis; Lila J Papadimitriou; Zoi P Retsou; Alexandra P Margeli; Sotirios S Ninos; John D Papadimitriou
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

View more
  40 in total

Review 1.  Are hematopoietic stem cells involved in hepatocarcinogenesis?

Authors:  Antonio Facciorusso; Matteo Antonino; Valentina Del Prete; Viviana Neve; Maria Principia Scavo; Michele Barone
Journal:  Hepatobiliary Surg Nutr       Date:  2014-08       Impact factor: 7.293

Review 2.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

Review 3.  Liver bioengineering: current status and future perspectives.

Authors:  Christopher Booth; Tom Soker; Pedro Baptista; Christina L Ross; Shay Soker; Umar Farooq; Robert J Stratta; Giuseppe Orlando
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 4.  The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells.

Authors:  Soona Shin; Klaus H Kaestner
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 5.  Stem cells, a two-edged sword: risks and potentials of regenerative medicine.

Authors:  Anna-Chiara Piscaglia
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

6.  Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival.

Authors:  Anna C Piscaglia; Thomas D Shupe; Giovanbattista Pani; Valentina Tesori; Antonio Gasbarrini; Bryon E Petersen
Journal:  J Hepatol       Date:  2009-04-05       Impact factor: 25.083

7.  Stem cell-based therapies for liver diseases: state of the art and new perspectives.

Authors:  Anna Chiara Piscaglia; Mariachiara Campanale; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Stem Cells Int       Date:  2010-09-01       Impact factor: 5.443

Review 8.  Stem cells in gastroenterology and hepatology.

Authors:  Michael Quante; Timothy C Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-03       Impact factor: 46.802

9.  Isolation and characterization of hepatic stem cells, or "oval cells," from rat livers.

Authors:  Thomas D Shupe; Anna C Piscaglia; Seh-Hoon Oh; Antonio Gasbarrini; Bryon E Petersen
Journal:  Methods Mol Biol       Date:  2009

Review 10.  Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis.

Authors:  Prasoon Pankaj; Qi Zhang; Xue-Li Bai; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.